
The trial is expected to begin in the first half of 2025, with results anticipated before the planned submission for regulatory approval in early 2026
Discover how we can elevate your portfolio and deliver exceptional growth. NEW Monthly Payout Of At Least 0.5% In US Dollars
Contact Us: bit.ly/Alpha-Binwani-Capital
Website: alphabinwanicapital.com
Facebook Group: bit.ly/AlgoFBGroup
#NovoNordisk #CagriSema #ClinicalTrials #ObesityResearch #Phase3Trial



















